Citations (28)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Kevin Rouault-Pierre, Ashley Hamilton & Dominique Bonnet. (2016) Effect of hypoxia-inducible factors in normal and leukemic stem cell regulation and their potential therapeutic impact. Expert Opinion on Biological Therapy 16:4, pages 463-476.
Read now
Read now
Harold Elias & Amit Verma. (2012) Activation of hypoxia signaling is marker of poor prognosis in myelodysplasia. Leukemia & Lymphoma 53:12, pages 2337-2338.
Read now
Read now
Articles from other publishers (26)
Hernán A. Tirado, Nithya Balasundaram, Lotfi Laaouimir, Ayşegül Erdem & Nick van Gastel. (2023) Metabolic crosstalk between stromal and malignant cells in the bone marrow niche. Bone Reports 18, pages 101669.
Crossref
Crossref
Livia E. Lisi-Vega & Simón Méndez-Ferrer. 2023.
Beibei Qu, Xiuhua Han, Lan Zhao, Feifei Zhang & Qingmei Gao. (2022) Relationship of HIF‑1α expression with apoptosis and cell cycle in bone marrow mesenchymal stem cells from patients with myelodysplastic syndrome. Molecular Medicine Reports 26:1.
Crossref
Crossref
Paige Dausinas Ni, Christopher Basile, Chase Junge, Melissa Hartman & Heather A. O’Leary. (2022) Hypoxia and Hematopoiesis. Current Stem Cell Reports 8:1, pages 24-34.
Crossref
Crossref
Neslihan Meriç & Fatih Kocabaş. 2022. Cell Biology and Translational Medicine, Volume 16. Cell Biology and Translational Medicine, Volume 16
127
144
.
Ekaterina Balaian, Manja Wobus, Martin Bornhäuser, Triantafyllos Chavakis & Katja Sockel. (2021) Myelodysplastic Syndromes and Metabolism. International Journal of Molecular Sciences 22:20, pages 11250.
Crossref
Crossref
Di Zhan & Christopher Y. Park. (2021) Stem Cells in the Myelodysplastic Syndromes. Frontiers in Aging 2.
Crossref
Crossref
Vassiliki Mpakou, Aris Spathis, Anthi Bouchla, Zoi Tsakiraki, Frieda Kontsioti, Sotirios Papageorgiou, Efthymia Bazani, Konstantinos Gkontopoulos, Thomas Thomopoulos, Irene Glezou, Athanasios Galanopoulos, Argiris Symeonidis, Panagiotis T. Diamantopoulos, Nora‐Athina Viniou, Christina‐Nefeli Kontandreopoulou, Kalliopi Zafeiropoulou, Ioannis Kotsianidis, Eleftheria Lamprianidou, Periklis Foukas, Aristoteles Mpamias & Vasiliki Pappa. (2021) Upregulated hypoxia inducible factor 1α signaling pathway in high risk myelodysplastic syndrome and acute myeloid leukemia patients is associated with better response to 5‐azacytidine—data from the Hellenic myelodysplastic syndrome study group. Hematological Oncology 39:2, pages 231-242.
Crossref
Crossref
Aikaterini Poulaki, Theodora Katsila, Ioanna E. Stergiou, Stavroula Giannouli, Jose Carlos Gόmez-Tamayo, Evangelia-Theophano Piperaki, Konstantinos Kambas, Aglaia Dimitrakopoulou, George P. Patrinos, Athanasios G. Tzioufas & Michael Voulgarelis. (2020) Bioenergetic Profiling of the Differentiating Human MDS Myeloid Lineage with Low and High Bone Marrow Blast Counts. Cancers 12:12, pages 3520.
Crossref
Crossref
Jiaxin Hu, Fanqiao Meng, Xian Hu, Lei Huang, Hui Liu, Zhaoyun Liu & Lijuanli Li. (2020) Iron overload regulate the cytokine of mesenchymal stromal cells through ROS/HIF-1α pathway in Myelodysplastic syndromes. Leukemia Research 93, pages 106354.
Crossref
Crossref
Hai‐wei Liang, Bin Luo, Li‐hua Du, Rong‐quan He, Gang Chen, Zhi‐gang Peng & Jie Ma. (2019) Expression significance and potential mechanism of hypoxia‐inducible factor 1 alpha in patients with myelodysplastic syndromes. Cancer Medicine 8:13, pages 6021-6035.
Crossref
Crossref
Paolo Alberto Lorenzini, Resilind Su Ern Chew, Cheryl Weiqi Tan, Jing Yen Yong, Fan Zhang, Jie Zheng & Xavier Roca. (2019) Human PRPF40B regulates hundreds of alternative splicing targets and represses a hypoxia expression signature. RNA 25:8, pages 905-920.
Crossref
Crossref
Zhaoyun Liu, Mengyue Tian, Kai Ding, Hui Liu, Yangyang Wang & Rong Fu. (2019) High expression of PIM2 induces HSC proliferation in myelodysplastic syndromes via the IDH1/HIF1‑α signaling pathway. Oncology Letters.
Crossref
Crossref
Niraj Shenoy, Mythri Mudireddy, Rangit Vallapureddy, Nelson Leung, Lance Pagliaro, Thomas Witzig, Fang-Shu Ou, Tamas Ordog, John Cheville, Mrinal Patnaik, R. Houston Thompson, Ayalew Tefferi & Kebede Begna. (2018) Association Between Renal Cell Carcinoma and Myelodysplastic Syndromes: Epigenetic Underpinning?. Clinical Genitourinary Cancer 16:6, pages e1117-e1122.
Crossref
Crossref
L Schito, S Rey & M Konopleva. (2017) Integration of hypoxic HIF-α signaling in blood cancers. Oncogene 36:38, pages 5331-5340.
Crossref
Crossref
Qing-qing Zheng, You-shan Zhao, Juan Guo, Si-da Zhao, Lu-xi Song, Cheng-ming Fei, Zheng Zhang, Xiao Li & Chun-kang Chang. (2017) Iron overload promotes erythroid apoptosis through regulating HIF-1a/ROS signaling pathway in patients with myelodysplastic syndrome. Leukemia Research 58, pages 55-62.
Crossref
Crossref
Christos K. Kontos, Sotirios G. Papageorgiou, Marios A. Diamantopoulos, Andreas Scorilas, Efthimia Bazani, Diamantina Vasilatou, Konstantinos Gkontopoulos, Eirini Glezou, Georgia Stavroulaki, George Dimitriadis & Vasiliki Pappa. (2017) mRNA overexpression of the hypoxia inducible factor 1 alpha subunit gene (HIF1A): An independent predictor of poor overall survival in chronic lymphocytic leukemia. Leukemia Research 53, pages 65-73.
Crossref
Crossref
Na Wang, Fei Wang, Ningning Shan, Xiaohui Sui & Hongzhi Xu. (2017) IDH1 Mutation Is an Independent Inferior Prognostic Indicator for Patients with Myelodysplastic Syndromes. Acta Haematologica 138:3, pages 143-151.
Crossref
Crossref
Laura Guerenne, Stéphanie Beurlet, Mohamed Said, Petra Gorombei, Carole Le Pogam, Fabien Guidez, Pierre de la Grange, Nader Omidvar, Valérie Vanneaux, Ken Mills, Ghulam J Mufti, Laure Sarda-Mantel, Maria Elena Noguera, Marika Pla, Pierre Fenaux, Rose Ann Padua, Christine Chomienne & Patricia Krief. (2016) GEP analysis validates high risk MDS and acute myeloid leukemia post MDS mice models and highlights novel dysregulated pathways. Journal of Hematology & Oncology 9:1.
Crossref
Crossref
Margaux Deynoux, Nicola Sunter, Olivier Hérault & Frédéric Mazurier. (2016) Hypoxia and Hypoxia-Inducible Factors in Leukemias. Frontiers in Oncology 6.
Crossref
Crossref
Ali N. Chamseddine, Elias Jabbour, Hagop M. Kantarjian, Zachary S. Bohannan & Guillermo Garcia-Manero. (2015) Unraveling Myelodysplastic Syndromes: Current Knowledge and Future Directions. Current Oncology Reports 18:1.
Crossref
Crossref
Erinn B. Rankin, Anupama Narla, Joseph K. Park, Shuo Lin & Kathleen M. Sakamoto. (2015) Biology of the bone marrow microenvironment and myelodysplastic syndromes. Molecular Genetics and Metabolism 116:1-2, pages 24-28.
Crossref
Crossref
Jose F. Falantes, Pablo Trujillo, Jose I. Piruat, Cristina Calder?n, Francisco J. M?rquez-Malaver, Beatriz Mart?n-Antonio, Africa Mill?n, Marina G?mez, Jose Gonz?lez, Maria L. Martino, Isabel Montero, Roc?o Parody, Ildefonso Espigado, Alvaro Urbano-Ispizua & Jose A. P?rez-Sim?n. (2015) Overexpression of GYS1, MIF, and MYC Is Associated With Adverse Outcome and Poor Response to Azacitidine in Myelodysplastic Syndromes and Acute Myeloid Leukemia. Clinical Lymphoma Myeloma and Leukemia 15:4, pages 236-244.
Crossref
Crossref
Jie Jin, Chao Hu, Mengxia Yu, Feifei Chen, Li Ye, Xiufeng Yin, Zhengping Zhuang & Hongyan Tong. (2014) Prognostic Value of Isocitrate Dehydrogenase Mutations in Myelodysplastic Syndromes: A Retrospective Cohort Study and Meta-Analysis. PLoS ONE 9:6, pages e100206.
Crossref
Crossref
Deniz Gezer, Milica Vukovic, Tomoyoshi Soga, Patrick J. Pollard & Kamil R. Kranc. (2014) Concise Review: Genetic Dissection of Hypoxia Signaling Pathways in Normal and Leukemic Stem Cells. Stem Cells 32:6, pages 1390-1397.
Crossref
Crossref
Sergio Manzetti & Oergis Tzamneti. (2013) Hypoxia-induced signaling and its relevance in discovering biomarkers for cancer research. Biomarkers and Genomic Medicine 5:4, pages 135-141.
Crossref
Crossref